Asian News International on MSN48m
Rifampicin drug used in TB treatment is expected to be commissioned later this year
"To effectively continue our goal of eliminating TB, consistent supply of essential first-line anti-tubercular drugs like Rifampicin is essential. During FY2023-24, India imported Rifampicin worth Rs ...
The Financial Express31m
Govt set to rollout key TB drug Rifampicin in India this year
The other important drugs like Prednisolone, Betamethasone and Dexamethasone are also expected to be commissioned this year.
Medical Dialogues16m
USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoea
Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...
The Manila Times15m
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...
SA pharmaceutical company wins battle over cancer drug
IN the face of a legal challenge by a multi-national pharmaceutical giant, a South African pharmaceutical company has fought ...
The Manila Times15m
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...
Research Analysts Issue Forecasts for SCYNEXIS FY2029 Earnings
Investment analysts at Brookline Capital Management issued their FY2029 EPS estimates for shares of SCYNEXIS in a report issued on Thursday, March 13th. Brookline Capital Management analyst K.
Teen noticed sign in her eye before rare brain tumour diagnosis
Teen noticed sign in her eye before rare brain tumour diagnosis - Joscelyne Kerr and her family are raising funds for a trial ...